The Deeplex® Myc-TB kit, developed by our supplier GenoScreen, is an innovative and integrated culture-free solution, which can provide a diagnosis on a strain’s resistance to 15 anti-TB drugs in less than two days. The assay is based on targeted deep sequencing or Next Generation Sequencing (NGS) and automated data analysis via the Deeplex® Myc-TB secure web application.

Deeplex® Myc-TB detects the TB heteroresistance down to 3%, and also identifies Non-Tuberculous Mycobacteria (NTM), as well as TB lineages and spoligotypes.

This innovative test guides the therapeutic management of TB patients in an effective way, by giving a rapid and extensive prediction of genetic resistance to anti-TB drugs.

The Deeplex® Myc-TB kit includes:

  • Deeplex® Master Mix: a single 24-plex PCR mix for culture-free amplification of 18 M. tuberculosis (MTBC) drug resistance-associated gene targets combined with targets for mycobacterial species identification and MTBC strain genotyping.
  • An internal control for in-sample quality control.
  • A positive control for test validation.
  • An activation code to access the Deeplex® Myc-TB web application.

Key aspects:

  • 15 anti-tuberculosis drugs screened
  • Only 48h from clinical samples to results
  • 3% heteroresistance detection sensitivity
  • >100 mycobacterial species detectable
  • 31 countries have implemented this solution

Area:

Bacteria, Microbiology

Brand:

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Sepsis Pathogenic Microorganism Detection Kit (Digital PCR)

In vitro diagnostic kit based on droplet digital PCR (dPCR) for the detection of pathogenic microorganisms associated with sepsis from DNA extracted from clinical samples. The kit allows identification and quantification of pathogens without requiring blood culture, covering 21 frequent agents in bloodstream infections. Detailed Description Principle of operation The Sepsis Pathogenic Microorganism Detection Kit…
RainSure
Digital PCR

VIASURE 16S V1-V4 NGS Solution

NGS solution for library preparation aimed at the simultaneous identification and profiling of microbial species present in DNA extracted from original samples, through the analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only (RUO) and not intended for diagnostic procedures. Detailed Description Principle of operation VIASURE 16S V1-V4…
Certest
Next Generation Sequencing (NGS)

PN-900 CandidaGenius® C. auris screening assay

Real‑time PCR assay for the rapid and direct detection of Candida auris from non‑invasive swabs, without the need for prior culture. Detailed Description The PN-900 CandidaGenius® C. auris screening assay is a molecular tool designed for the qualitative detection of Candida auris DNA by real‑time PCR. This emerging fungus represents a growing challenge in the…
Pathonostics
Real Time PCR (qPCR)

Illumina Viral Surveillance Panel v2

Next‑generation sequencing (NGS) assay with hybrid capture enrichment for the detection and whole‑genome sequencing of approximately 200 RNA and DNA viruses relevant to public health. It integrates library preparation, enrichment, sequencing, and data analysis into an optimized workflow of about two days. Detailed Description Principle of operation The panel can start from RNA, DNA, or…
Illumina
Next Generation Sequencing (NGS)